← Open Payments lookup

MICHELLE PAVLISH: Open Payments

NPI 1518333541 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$477 in 19 payments from 11 companies in 2025. Trend: 2023 $363 · 2024 $173 · 2025 $477

Food & beverage: $477
CompanyPaymentsAmount
ABBVIE INC.6$224
Lilly USA, LLC3$53
Novo Nordisk Inc2$44
Janssen Pharmaceuticals, Inc1$30
SANOFI-AVENTIS U.S. LLC1$26
Otsuka America Pharmaceutical, Inc.1$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$17
Axsome Therapeutics, Inc.1$17
Merck Sharp & Dohme LLC1$14
AstraZeneca Pharmaceuticals LP1$14

Products named: QULIPTA, Wegovy, VRAYLAR, MOUNJARO, SPRAVATO, TZIELD, REXULTI, UBRELVY.

Industry payments across NE — which companies pay providers there.